[Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day].

Published in: Terapevticheskii arkhiv (2021)

The concentration of endogenous GLP-1 before the appointment of liraglutide therapy at a dose of 3.0 mg per day can be used for prediction the drug hypoglycemic effect and achieving normoglycemia possibility.

Keyphrases

prognostic factors
insulin resistance
metabolic syndrome
weight loss
type diabetes
weight gain
high fat diet induced
emergency department
stem cells
physical activity
mesenchymal stem cells
bone marrow
replacement therapy